BRIEF published on 08/31/2026 at 07:05, 6 days 21 hours ago Advicenne withdraws the application for registration of ADV7103 in the United States FDA Pharmaceutical Registration Advicenna Sibnayal
BRIEF published on 08/31/2026 at 07:05, 6 days 21 hours ago Advicenne retire la demande d'enregistrement d'ADV7103 aux États-Unis FDA Pharmaceutique Advicenne Sibnayal Enregistrement
PRESS RELEASE published on 08/31/2026 at 07:00, 6 days 21 hours ago Inside Information / Other news releases Advicenne voluntarily withdraws NDA for ADV7103 in the USA due to CMC-related work issues. Company hosting French webinar for shareholders. ADV7103 approved in EU, UK, KSA, UAE Pharmaceutical Webinar Advicenne ADV7103 NDA Withdrawal
PRESS RELEASE published on 08/31/2026 at 07:00, 6 days 21 hours ago Informations privilégiées / Autres communiqués Advicenne retire la demande d'enregistrement de ADV7103 aux Etats-Unis pour le traitement de l'Acidose Tubulaire Rénale distale primaire, en raison de travaux complémentaires requis dans le domaine CMC Advicenne Retrait ADV7103 Acidose Tubulaire Rénale Demande D'enregistrement
BRIEF published on 07/16/2026 at 18:40, 1 month 21 days ago Advicenne's Revenue Surge in First Half of 2026 Revenue Growth Advicenne Sibnayal® Likozam® Pharmaceutical Sales
BRIEF published on 07/16/2026 at 18:40, 1 month 21 days ago Forte hausse du chiffre d'affaires d'Advicenne au premier semestre 2026 Croissance Des Revenus Advicenne Sibnayal® Likozam® Ventes Pharmaceutiques
PRESS RELEASE published on 07/16/2026 at 18:35, 1 month 21 days ago Informations privilégiées / Autres communiqués Advicenne annonce un chiffre d'affaires net du premier semestre 2026 en forte croissance grâce au remboursement de Sibnayal® et Likozam® en France Chiffre D'affaires Croissance Advicenne Sibnayal® Likozam®
PRESS RELEASE published on 07/16/2026 at 18:35, 1 month 21 days ago Inside Information / Other news releases Advicenne reports significant revenue growth in first half of 2026 driven by Sibnayal® and Likozam® reimbursement in France, ending negative impact of early access rebates. Sales of Sibnayal® and Likozam® increased in volume Revenue Growth France Advicenne Sibnayal® Likozam®
BRIEF published on 07/01/2026 at 17:50, 2 months 5 days ago Unlimited renewal of the marketing authorization for Sibnayal® by Advicenne in the United Kingdom United Kingdom Advicenna Sibnayal Rare Kidney Diseases Marketing Authorization Renewal
BRIEF published on 07/01/2026 at 17:50, 2 months 5 days ago Renouvellement illimité de l'AMM de Sibnayal® par Advicenne au Royaume-Uni Royaume-Uni Advicenne Maladies Rénales Rares Sibnayal Renouvellement AMM
Published on 09/05/2026 at 04:05, 2 days ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 5 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 5 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 6 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 14 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/06/2026 at 21:55, 6 hours 58 minutes ago DUVA Introduces DUVA ONE at IFA 2026: Personalized Sleep Earbuds That Respond in Real Time
Published on 09/06/2026 at 12:30, 16 hours 23 minutes ago MERACH Introduces the UltraWalk W60 Plus - A Walking Pad Designed for the Modern Home and Home Office
Published on 09/06/2026 at 10:25, 18 hours 28 minutes ago Over 400 media professionals seek new drivers for Asia-Pacific growth
Published on 09/06/2026 at 10:00, 18 hours 53 minutes ago Haier Showcases AI-Powered Smart Home Ecosystem at IFA 2026
Published on 09/06/2026 at 06:00, 22 hours 52 minutes ago CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/04/2026 at 18:57, 2 days 9 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 2 days 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 2 days 10 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 10 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 10 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026
